First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

NCT01568203 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class

Stopped Amgen decision (business)

Conditions

Interventions

Sponsor

Amgen